Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report)’s stock price traded up 0.7% during trading on Tuesday . The stock traded as high as €27.69 ($29.77) and last traded at €27.59 ($29.67). 2,430,000 shares changed hands during trading, The stock had previously closed at €27.40 ($29.46).
Bayer Aktiengesellschaft Trading Up 0.7 %
The company has a debt-to-equity ratio of 136.06, a current ratio of 1.27 and a quick ratio of 0.72. The firm’s 50 day moving average price is €27.33 and its 200 day moving average price is €32.00. The stock has a market capitalization of $27.10 billion, a P/E ratio of -9.23, a P/E/G ratio of 36.39 and a beta of 0.97.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Roth IRA Calculator: Calculate Your Potential Returns
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Hilton Demonstrates Asset Light is Right for Investors
- Industrial Products Stocks Investing
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
